Board Committees

Dr. Hosseinion, 46, is a co-founder of Apollo Medical Holdings, Inc., has been a member of its board of directors since July 2008, and served as its Chief Executive Officer from July 2008 to December 2017 and Co-Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion was Chairman of the board of directors of Clinigence Holdings, Inc. from April 2019 to March 2022, Chief Executive Officer of Clinigence Holdings, Inc. from March 2021 to March 2022, and following a business combination with Nutex Health, Inc. he continues to be a director and President of Nutex Health, Inc. from March 2022 to present. In 2001, Dr. Hosseinion co-founded ApolloMed. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in physiology and biophysics from the Georgetown University Graduate School of Arts and Sciences, his medical degree from the Georgetown University School of Medicine, and completed his residency in internal medicine from the Los Angeles County-University of Southern California Medical Center.

Hilton Sturisky is currently the Chief Information Officer (CIO) for Caesars Entertainment Digital (2020 - Present).  He was previously the Global CIO of Crawford & Company (NYSE: CRD.B), the world’s largest publicly listed insurance claims management company. Sturisky has extensive travel industry experience, having served as the CIO of both Spirit Airlines (NYSE: SAVE) and BCD Travel. He has also held leadership roles at Pfizer Pharmaceuticals (NYSE: PFE) and The Coca-Cola Company (NYSE: KO). Sturisky has spent his career restructuring large scale operating models involving disparate IT functions and legacy systems in high transaction complex environments, and he is well-versed in leveraging digital technology to enhance customer experience, obtain insight from data, and drive aggressive growth and innovation across diverse industries. He received his bachelor’s degree from the University of Witwatersrand in Johannesburg, South Africa, as well as graduate degrees from Emory University and Georgia Tech.

Dr. Hosseinion, 46, is a co-founder of Apollo Medical Holdings, Inc., has been a member of its board of directors since July 2008, and served as its Chief Executive Officer from July 2008 to December 2017 and Co-Chief Executive Officer from December 2017 to March 2019. Dr. Hosseinion was Chairman of the board of directors of Clinigence Holdings, Inc. from April 2019 to March 2022, Chief Executive Officer of Clinigence Holdings, Inc. from March 2021 to March 2022, and following a business combination with Nutex Health, Inc. he continues to be a director and President of Nutex Health, Inc. from March 2022 to present. In 2001, Dr. Hosseinion co-founded ApolloMed. Dr. Hosseinion received his B.S. in Biology from the University of San Francisco, his M.S. in physiology and biophysics from the Georgetown University Graduate School of Arts and Sciences, his medical degree from the Georgetown University School of Medicine, and completed his residency in internal medicine from the Los Angeles County-University of Southern California Medical Center.

Michel Taride is a Strategic Advisor in travel, tourism and smart mobility at Orfeo Partners and a Senior Advisor at Afiniti and Drake Star Partners. Taride is also an Operating Partner at C4 Ventures and a Strategic Advisor at Knighthood Capital Partners. Previously, he was the Group President of Hertz International (OTCPK: HTZGQ), the leading global car rental brand, where he was responsible for all of Hertz’s wholly owned and franchise operations in approximately 150 countries across all continents other than North America. Taride has served on the Global Travel & Tourism Partnership Advisory Board for over a decade and as the board’s Chairman for the last five years, and he holds concurrent appointments as an Ambassador for the World Travel and Tourism Council and a Foreign Trade Advisor to the French Embassy in London. Taride received his master’s degree from the Faculte de Droit et Sciences Economiques in Nice, France.